dr. Almitra Rindiarti, Ph.D.

Research Interest

  • Hematology
  • Leukemia
  • Drug resistance

Biography

Dr. Almitra Rindiarti graduated from the Faculty of Medicine, Universitas Indonesia in 2010 (Cum Laude). After working as visiting researcher in Pediatric Department, Kagoshima University in 2015, she decided to pursue a Ph.D. in Pediatric Hemato-Oncology under the supervision of Prof. Yoshifumi Kawano and Prof. Yasuhiro Okamoto from 2016. Her main thesis project focused on the development of chemotherapy resistant T-ALL cell line and elucidation of its drug resistance mechanism. During her study she was awarded the Otsuka Toshimi Scholarship from Otsuka Toshimi Foundation. She received her Doctorate in 2022 and joined i3L as biomedicine faculty member. 

dr. Almitra Rindiarti ,Ph.D.

Award and Industrial Collaboration

Year

Award and Industrial Collaboration

Source

2024/2025

Evaluation of the Wound Healing Activity of Indonesian Propolis

PT Sains Inovasi Indonesia

 

Research Activity and Highlighted Project

Year

Source

Title

Partners/Funding Agency

2025/2026

Institution

Investigating Keratinocyte Responses to Conditioned Media from A549 Wild-Type and Resistant Cells

i3L Internal Grant

2025/2026

Institution

Exploring the Regenerative Effects of Various Pure Essential Oils on Human Skin Keratinocytes Under UVB-Induced Damage

i3L Internal Grant

2024/2025

Institution

Alkaline pH as a Promoter of Tumor Progression in Lung Adenocarcinoma: Cellular and Molecular Investigation

i3L Internal Grant

2024/2025

Institution

Comparative Analysis of Warburg Effect Gene Expression in Lung Adenocarcinoma: The Impact of Patients Smoking Status and Clinical Profiles

Universitas Indonesia – Persahabatan National Respiratory Center Hospital / i3L

 

Selected Publication

Prawira, F., Alexandra, C., Tong, Y. W., Hartrianti, P., Rindiarti, A., Chen, A. C., & Lei, K. F. (2026). A biomimetic folding paper co-culture system for analyzing cellular crosstalk in bone healing: Interactions of bone morphogenetic protein-2, Wnt family member 1, periostin, and platelet-derived growth factor subunit A between periosteum-derived progenitor cells and adipose-derived stem cells. Talanta, 298(Pt A), 128943. https://doi.org/10.1016/j.talanta.2025.128943

Rindiarti, A., Okamoto, Y., Nakagawa, S., Hirose, J., Kodama, Y., Nishikawa, T., & Kawano, Y. (2022). Changes in intracellular activation-related gene expression and induction of Akt contribute to acquired resistance toward nelarabine in CCRF-CEM cell line. Leukemia & Lymphoma, 63(2), 404–415. https://doi.org/10.1080/10428194.2021.1992617